• PROMOTE YOUR VENTURE
    • Startup listings
    • IP & Tech listings
  • GET HELP
    • Search questions
    • Post projects
    • Search expert directory
  • RESOURCES
    • Document Center
    • Search for patents
    • Expert articles / posts
  • NEWS & EVENTS
    • Tech & IP News
  • My Account
  • Sign in
  • FOR PROFESSIONALS

Patents

68,025 found
SEE ALL IP TYPES
PATENTFIELD SEARCH
UPLOAD IP
Granted

Fourier domain low-coherenc...

The Fourier-domain version of the a/LCI system uses a superluminescent diode (SLD) with a fiber-coupled output as the light source. A fiber splitter separates the signal path at 90% intensity and t...

Granted

CD20-specific antibodies

CD20 is the target of the monoclonal antibodies (mAb) rituximab, Ibritumomab tiuxetan, and tositumomab, which are all active agents in the treatment of all B cell lymphomas and leukemias. The an...

Pending

Ligand

In biochemistry and pharmacology, a ligand (from the Latin ligandum, binding) is a substance (usually a small molecule) that forms a complex with a biomolecule to serve a biological purpose. In pro...

Pending

Severe acute respiratory sy...

Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the SARS coronavirus (SARS-CoV). Between November 2002 and July 2003, an outbreak of SARS in sou...

Pending

Allergic asthma

Asthma (from the Greek ἅσθμα, ásthma, "panting") is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction and broncho...

Pending

Inducing neutralizing antib...

Inducing neutralizing antibodies against HIV

Granted

Broadband interferometry

Broadband interferometry

Granted

Fourier domain optical coh...

SEFD-OCT extracts spectral information by distributing different optical frequencies onto a detector stripe (line-array CCD or CMOS) via a dispersive element (see Fig. 4). Thereby the information o...

Pending

S-nitrosoglutathione reduct...

In enzymology, a formaldehyde dehydrogenase (EC 1.2.1.46) is an enzyme that catalyzes the chemical reaction formaldehyde + NAD+ + H2O \rightleftharpoons formate + NADH + H+ The 3 substrates of ...

Pending

Inositol phosphate kinases

Inositol phosphate kinases

Granted

Inducing neutralizing HIV p...

Inducing neutralizing HIV primary isolates

Granted

Inducing neutralizing HIV p...

Inducing neutralizing HIV primary isolates

Pending

Insulin resistance

Insulin resistance (IR) is a physiological condition in which cells fail to respond to the normal actions of the hormone insulin. The body produces insulin, but the cells in the body become resista...

Pending

Risk for musculoskeletal, a...

Risk for musculoskeletal, arthritic, joint disorders

Pending

Thiol reactive agent

Thiol reactive agent

Pending

Hypoxia-inducible factor 1-...

Hypoxia-inducible factor 1-alpha, also known as HIF-1-alpha, is a protein that in humans is encoded by the HIF1A gene.[1][2] Two alternative transcripts encoding different isoforms have been identi...

Granted

Nitroglycerin therapy

Nitroglycerin was first used by William Murrell to treat anginal attacks in 1878, with the discovery published that same year.[8][20] Nitroglycerin belongs to a group of drugs called nitrates, w...

Granted

Perioperative bleeding/Rena...

Perioperative bleeding/Renal dysfunction

Granted

Charcot–Marie–Tooth disease

Charcot–Marie–Tooth disease (CMT), also known as Charcot–Marie–Tooth neuropathy, hereditary motor and sensory neuropathy (HMSN) and peroneal muscular atrophy (PMA) — is a genetically and clinically...

Pending

Optical fiber illuminators

Optical fiber illuminators

  • First
  • Prev
  • …
  • 1922
  • 1923
  • 1924
  • 1925
  • 1926
  • 1927
  • 1928
  • 1929
  • 1930
  • …
  • Next
  • Last
Your one-stop shop for innovation and intellectual property Join us today

About us

IP Nexus is an IP commercialisation company that builds successful startup companies by collaborating with inventors, universities and research institutes to identify high-potential inventions at an early stage and provide the commercial direction, fundraising expertise and management talent necessary to build outstanding companies. IP Nexus has particular focus and expertise in Asia.

Disclaimer

IP Nexus, including the Ask an Expert and Services Marketplace, is an interactive online service that makes it faster and easier for businesses to find and hire legal help solely based on their search preferences. We are not a law firm, do not provide any legal services, legal advice or lawyer referral services and do not provide or participate in any legal representation.

Content

  • PRICING
  • FREQUENTLY ASKED QUESTIONS
  • IP PROTECTION
  • IP TYPES
  • IP CLAIMS
  • OUR TEAM
  • STARTUPS
  • CONTACT US
  • BRAND ASSETS
  • TERM OF USE
  • PRIVACY POLICY
  • SEARCH PATENTS ON PATENTFIELD

Newsletter

Subscribe

Languages

© 2026 IP Nexus. All Rights Reserved.

Report content

      Contact form